Delivery Order SPE2DB20D3111-SPE2DB25FA6MW

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,352.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-500 MG TABLET 180S, a medication used for the treatment of diabetes. The contract is a firm fixed-price Delivery Order and has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,433.17 firm fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award, valued at $2,966.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 19, 2024. The contract was not designated with a set-aside...
This federal contract award, valued at $2,843.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used in the management of diabetes. The contract has a firm fixed price and an ultimate completion date of August 30, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $5,205.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a completion date of December 4, 2024. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,366.98 Firm Fixed Price Delivery Order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is a delivery order valued at $3,114.55 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUMET XR 50-1,000 mg tablets, a medication used to treat diabetes. The award has an ultimate completion date of December 9, 2024 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,885.75 firm-fixed-price delivery order is for the supply of JANUMET XR 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. This award is a part of Amerisourcebergen's existing $999,999,999 Indefinite...
This federal contract award, valued at $107,585.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 26, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $11,362.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The delivery order has a firm fixed price and an ultimate completion date of January 28, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6MW
    Delivery Order

This federal contract award, valued at $1,563.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a drug used for diabetes management. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/30/25, 9:42 AM